BIEDIGER RONALD J.,CHEN QI,HOLLAND GEORGE W.,KASSIR JAMAL M.,LI WEN,MARKET ROBERT V.,SCOTT IAN L.,WU CHENGDE
申请号：
SI200100288
公开号：
SI21096B
申请日:
2001.11.05
申请国别(地区):
SI
年份:
2012
代理人:
摘要：
A method for the inhibition of the binding of alpha4beta1 integrin to its receptors, for example VCAM-1 (vascular cell adhesion molecule-1) and fibronectin compounds that inhibit this binding pharmaceutically active compositions comprising such compounds and to the use of such compounds either as above, or in formulations for the control or prevention of diseases states in which alpha4beta1 is involved.Postopek za inhibiranje vezave alfa beta integrina na njegove receptorje npr VCAM vaskularna celična adhezijska molekula in fibronektin spojine ki inhibirajo to vezavo farmacevtsko aktivni sestavki ki obsegajo take spojine in uporaba takih spojin bodisi kot zgoraj ali v pripravkih zakontrolo ali preprečevanje bolezenskih stanj v katera je vpleten alfa beta
